Our research demonstrates a novel molecular mechanism of the function of MFGE8 in EndMT and further proves the use of MFGE8 as a potential circulating biomarker or therapeutic target for diagnosis and mitigation of CF and CF‐related heart failure. Here, MFGE8 is linked to heart failure.